← Research library

Use of cortexin in the early rehabilitation period of ischemic stroke of moderate severity

Comparison in people · 2009

What was studied
68 early-rehabilitation patients; 35 adjunctive Cortexin, 33 basic therapy
Main finding
Motor and cognitive outcomes favored adjunctive Cortexin over basic therapy during short follow-up.

Global-state improvement · 27/35 (77.1%) versus 18/33 (54.5%) · End of treatment

Reported findings and study design

68 stroke rehabilitation patients: Cortexin 35 versus basic treatment 33; age 60.5 ± 2.8 years. Add-on Cortexin 10 mg IM daily for ten days.

Population or model 68 early-rehabilitation patients; 35 adjunctive Cortexin, 33 basic therapy

Dose, route and schedule

Cortexin: 10 mg intramuscularly daily for 10 days, added to basic treatment during early ischemic-stroke rehabilitation. Controls received basic treatment alone.

Protocol source ↗ · Indexed publication abstract

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Global-state improvement27/35 (77.1%) versus 18/33 (54.5%)End of treatment
Motor/cognitive rehabilitation comparisonCortexin favoredp<0.05
Treatment adverse effectsNone observed in this small comparison

Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • Allocation and masking are unclear in the abstract.
  • Short follow-up and limited safety reporting do not establish sustained independence or safety.

Source details

Indexed citation and abstract reviewed via Europe PMC / PubMed; full methods and risk of bias not comprehensively appraised.

Abstract reviewed

Sources checked

Citation

Human comparative studyEnglish abstract

Nurguzhaev ES, Mitrokhin DA, Izbasarova ASh, Nurguzhaev AE, Raimkulov BN, Abdil'manova BR. Use of cortexin in the early rehabilitation period of ischemic stroke of moderate severity Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · PMID 19672239

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards